Skip to main content
. 2012 Jan 26;8(1):e1002480. doi: 10.1371/journal.ppat.1002480

Figure 2. Presence of an 80-gene blood transcriptional signature in HAM/TSP.

Figure 2

The blood expression levels of 80 genes differed between patients with HAM/TSP and clinically asymptomatic HTLV-1 carriers and uninfected individuals. (A) Microarray training and (B) test set gene expression profiles. Participants were clustered in hierarchical condition trees (Spearman correlation with average linkage) with each row representing a single gene and each column an individual subject. Color scale indicates normalized expression values and colored boxes below the trees indicate the individual's clinical classification (study group). ACs with high or low HTLV-1 proviral load were not distinguished by color because their results did not differ significantly either in hierarchical clustering or WMDH analysis. (C) Quantification of transcriptional changes in the 80 genes. The ‘weighted molecular distance to health’ metric [12] was calculated for each patient and the median compared between study groups (Mann-Whitney test). (D) Correlation between the transcriptional signature and the clinical severity of HAM/TSP. Extent of impaired mobility was assessed by patients' performance in the 10-meter walk test (see methods). Graphs (C) and (D) comprise data of the training and test set. PVL = HTLV-1 proviral load. Box plot represent median ± 1.5 IQR. The P-values were calculated using a two-tailed Mann-Whitney test.